• Pharmacological and Combination Interventions for Nicotine Cessation
    Jun 30 2026

    Master the latest evidence-based meds and dual therapies to help your patients quit for good.

    Credit available for this activity expires: 06/25/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.staging.medscape.org/viewarticle/pharmacological-and-combination-interventions-nicotine-2026a1000ldi?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    33 mins
  • Is Normalizing Hemostasis an Achievable Goal in Hemophilia A?
    Jun 26 2026

    Is sustained hemostatic normalization achievable across all hemophilia A patients? Examine the evidence behind today's therapeutic advances.

    Credit available for this activity expires: 6/26/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/normalizing-hemostasis-achievable-goal-hemophilia-2026a1000jxv?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    30 mins
  • The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management
    Jun 26 2026

    Drs García-Pavia and Sperry break down the top 5 mistakes in transthyretin amyloid cardiomyopathy (ATTR-CM) management and share clinical solutions for earlier, optimized patient care.

    Credit available for this activity expires: 6/25/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/top-5-errors-transthyretin-amyloid-cardiomyopathy-management-2026a1000jpe?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    18 mins
  • Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice
    Jun 23 2026

    Learn to optimize durability and drying with new second-generation anti-VEGF therapies.

    Credit available for this activity expires: 6/19/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/https://www.medscape.org/viewarticle/better-drying-longer-lasting-second-generation-anti-vegf-2026a1000k53?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    37 mins
  • Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies
    Jun 17 2026

    Do you know how tumor-agnostic therapies are helping to reshape cancer treatment pathways?

    Credit available for this activity expires: 6/16/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/shaping-future-precision-oncology-biomarker-driven-care-2026a1000jpk?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    23 mins
  • Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors
    Jun 17 2026

    Which patients with Alagille syndrome benefit from IBAT inhibitors, and what should you watch for during therapy?

    Credit available for this activity expires: 6/16/27
    Earn Credit / Learning Objectives & Disclosures:
    https://www.medscape.org/viewarticle/navigating-management-alagille-syndrome-using-ileal-bile-2026a1000g3c?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    22 mins
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy Care Partnerships: Aligning Goals for Better Outcomes
    Jun 5 2026

    How does it feel to live with CIDP? Bridge the gap between metrics and patient reality. Align goals and improve outcomes via shared decision-making.

    Credit available for this activity expires: 6/4/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-inflammatory-demyelinating-polyradiculoneuropathy-2026a1000g2n?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    26 mins
  • The Molecular Nuances of Hemostasis: Differentiating FVIII and Non-Factor Replacement
    Jun 2 2026

    Do you know how the different therapies act in hemophilia A?

    Credit available for this activity expires: 05/29/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/molecular-nuances-hemostasis-differentiating-fviii-and-non-2026a1000hk2?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    29 mins